BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 162 filers reported holding BIOLIFE SOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 86.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,982,067 | -37.5% | 360,758 | 0.0% | 4.17% | -21.9% |
| Q2 2023 | $7,972,751 | +1.6% | 360,758 | 0.0% | 5.34% | +1.3% |
| Q1 2023 | $7,846,486 | +41.4% | 360,758 | +18.3% | 5.27% | +40.6% |
| Q4 2022 | $5,549,362 | -20.0% | 304,910 | 0.0% | 3.75% | -16.6% |
| Q3 2022 | $6,937,000 | +64.7% | 304,910 | 0.0% | 4.49% | +76.2% |
| Q2 2022 | $4,211,000 | -10.1% | 304,910 | +48.0% | 2.55% | +18.2% |
| Q1 2022 | $4,682,000 | -28.3% | 205,968 | +17.5% | 2.16% | -16.9% |
| Q4 2021 | $6,532,000 | -11.9% | 175,275 | 0.0% | 2.60% | -11.8% |
| Q3 2021 | $7,418,000 | -14.4% | 175,275 | -10.0% | 2.94% | -10.7% |
| Q2 2021 | $8,668,000 | +23.6% | 194,750 | 0.0% | 3.30% | +14.1% |
| Q1 2021 | $7,011,000 | -9.8% | 194,750 | 0.0% | 2.89% | -17.3% |
| Q4 2020 | $7,769,000 | +37.8% | 194,750 | 0.0% | 3.49% | +0.9% |
| Q3 2020 | $5,636,000 | +189.0% | 194,750 | +63.3% | 3.46% | +146.6% |
| Q2 2020 | $1,950,000 | – | 119,281 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,780,000 | $107,441,800 | 11.89% |
| Gagnon Advisors, LLC | 360,758 | $4,982,067 | 4.17% |
| Meros Investment Management, LP | 372,203 | $5,140,123 | 2.80% |
| Park West Asset Management LLC | 2,014,954 | $27,826,515 | 2.56% |
| GAGNON SECURITIES LLC | 633,363 | $8,746,743 | 2.19% |
| Mesirow Financial Investment Management, Inc. | 26,710 | $368,865 | 1.60% |
| Roubaix Capital, LLC | 146,898 | $2,028,661 | 1.50% |
| Millrace Asset Group, Inc. | 48,917 | $676 | 0.84% |
| Soleus Capital Management, L.P. | 439,000 | $6,062,590 | 0.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,363,638 | $18,831,841 | 0.53% |